ÇÙ»ê°Ë»ç(NAT) ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Nucleic Acid Testing Market Report by Product Type, Technology, End User, and Region 2025-2033
»óǰÄÚµå : 1800871
¸®¼­Ä¡»ç : IMARC
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 142 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,221,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,628,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,036,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ÇÙ»ê°Ë»ç(NAT) ½ÃÀå ±Ô¸ð´Â 2024³â 32¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 53¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 5.39%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

ÇÙ»ê°Ë»ç(NAT)´Â ȯÀÚÀÇ Ç÷¾×, Á¶Á÷, ¼Òº¯¿¡¼­ ¹ÙÀÌ·¯½º, ¼¼±Õ, º´¿ø¼º ÇÙ»êÀ» °Ë»çÇÏ´Â ºÐÀÚ ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ¹ýÀÇÇÐÀû °Ë»ç ¹× ¼öÇ÷°¨¿°Áõ, À¯Àüº´, ¾Ï Áø´ÜÀ» À§ÇØ ½ÃÇàµË´Ï´Ù. ÇÙ»ê(NA) ÃßÃâ, Ç¥Àû NA ÁõÆø, Ç¥Àû amplicon NA °ËÃâÀ» ÅëÇÑ »ùÇà ǮÀ» Æ÷ÇÔÇÕ´Ï´Ù. °Ë»ç¿¡´Â ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR), »ç½½Ä¡È¯ÁõÆø(SDA), ¸®°¡Á¦¿¬¼â¹ÝÀÀ(LCR), Àü»ç¸Å°³ÁõÆø(TMA), NA ¼­¿­±â¹ÝÁõÆø(NASBA) °úÁ¤À» ¼öÇàÇϱâ À§ÇÑ Å°Æ®¿Í ¼Ò¸ðǰÀÌ Æ÷ÇԵ˴ϴÙ. NAT´Â ¶ÇÇÑ ´«¿¡ º¸ÀÌ´Â Áõ»óÀÌ ¾ø´Â Áúº´À» ½Äº°ÇÏ°í °¡¹ÝÀÀ¼º ÇØ¼®À» ÇØ°áÇÏ´Â µ¥µµ »ç¿ëµË´Ï´Ù.

¼¼°èÀûÀ¸·Î ¹ÚÅ׸®¾Æ ¹× ¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ À¯ÇàÀÌ Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ÷´Ü Áø´Ü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó Äڷγª19ÀÇ ¹ßº´µµ Ç׿øÀ» °¨ÁöÇÏ´Â NAT ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. NAT´Â °¨¿°º´À» È¿°úÀûÀ¸·Î °ü¸®ÇÏ°í °¨¿°¿øÀ» Á¤È®ÇÏ°Ô ÆÄ¾ÇÇϱâ À§ÇØ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈ£ ¹× ÇÁ·Îºê ÁõÆø ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ »õ·Î¿î »ý¹°ÇÐÀû Áø´Ü ±â¼ú °³¹ß µî ´Ù¾çÇÑ ±â¼ú ¹ßÀüÀÌ ¶Ç ´Ù¸¥ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ±â¼úÀº Áúº´À» Á¶±â¿¡ ¹ß°ßÇÏ°í ¹ÙÀÌ·¯½º °¨¿° ±â°£À» ÃÖ¼ÒÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ±âŸ ¿äÀÎÀ¸·Î´Â ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß(R&D) Ȱµ¿, ÇコÄɾî ÀÎÇÁ¶ó °³¼± µîÀÌ ½ÃÀåÀ» ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ÇÙ»ê°Ë»ç(NAT) ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global nucleic acid testing market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.39% during 2025-2033.

Nucleic acid testing (NAT) refers to a molecular technique for screening viruses, bacteria or pathogenic nucleic acid in the blood, tissue or urine of the patient. It is conducted for forensic testing and to diagnose transfusion-transmitted infections, genetic diseases and cancer. It involves sample pooling through nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection. The testing involves kits and consumables for performing polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and NA sequence-based amplification (NASBA) processes. NAT is also used for the identification of diseases with no visible symptoms and resolving false reactive interpretations.

The increasing prevalence of infectious bacterial and viral diseases across the globe represents one of the key factors driving the growth of the market. Furthermore, the increasing demand for advanced diagnostic systems is also driving the market growth. In line with this, the onset of the coronavirus disease (COVID-19) has also enhanced the demand for NAT solutions to detect the antigens. NAT is widely used for the effective management of communicable diseases and accurate identification of the infecting agent. Additionally, various technological advancements, such as the development of novel biological diagnostic techniques, including signal and probe amplification systems, are acting as other growth-inducing factors. These innovative techniques aid in the early detection of the disease and minimizing the infectious period of the virus. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

Breakup by Technology:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, Siemens Healthcare, Tecan Group AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Nucleic Acid Testing Market

6 Market Breakup by Product Type

7 Market Breakup by Technology

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â